These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 28720156

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Does theFMR1 gene affect IVF success?
    Pastore LM, Christianson MS, McGuinness B, Vaught KC, Maher JY, Kearns WG.
    Reprod Biomed Online; 2019 Apr; 38(4):560-569. PubMed ID: 30711457
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high FMR1 premutation prevalence in the Balearic Islands.
    Alfaro Arenas R, Rosell Andreo J, Heine Suñer D, Group for the study of FXS in the Balearic Islands.
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1023-1031. PubMed ID: 27333191
    [Abstract] [Full Text] [Related]

  • 26. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
    Sølvsten C, Nielsen AL.
    Gene; 2011 Oct 15; 486(1-2):15-22. PubMed ID: 21767618
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A, Teicher J, Rohlfs EM, Donnenfeld A, Hallam S.
    Obstet Gynecol; 2008 Mar 15; 111(3):596-601. PubMed ID: 18310361
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Defining the Performance Parameters of a Rapid Screening Tool for FMR1 CGG-Repeat Expansions Based on Direct Triplet-Primed PCR and Melt Curve Analysis.
    Rajan-Babu IS, Lian M, Tran AH, Dang TT, Le HT, Thanh MN, Lee CG, Chong SS.
    J Mol Diagn; 2016 Sep 15; 18(5):719-730. PubMed ID: 27375073
    [Abstract] [Full Text] [Related]

  • 38. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing.
    Gasteiger M, Grasbon-Frodl E, Neitzel B, Kooy F, Holinski-Feder E.
    Genet Test; 2003 Sep 15; 7(4):303-8. PubMed ID: 15000806
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.